- (a) Specifications. Each milliliter of solution contains prochlorperazine edisylate equivalent to 4 milligrams (mg) prochlorperazine and isopropamide iodide equivalent to 0.28 mg of isopropamide.
- (b) Sponsor. See No. 054771 in § 510.600(c) of this chapter.
(c) Conditions of use—(1) Amount.
(i) Dosage is administered by subcutaneous injection twice daily as follows:
| Weight of animal in pounds | Dosage inmilliliters |
|---|
| Up to 4 | 0.25 |
| 5 to 14 | 0.5-1 |
| 15 to 30 | 2-3 |
| 30 to 45 | 3-4 |
| 45 to 60 | 4-5 |
| Over 60 | 6 |
- (ii) Following the last injection, administer prochlorperazine and isopropamide sustained release capsules as indicated.
- (2) Indications for use. For use in dogs and cats in which gastrointestinal disturbances are associated with emotional stress.
- (3) Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
[79 FR 16194, Mar. 25, 2014]